Lima’s solutions include digital innovation and patient-tailored hardware, developed to improve patient outcomes following joint replacement surgery.
The acquisition is intended to expand BSC’s portfolio to provide more treatment options for chronic low back pain.
Axolotl designs, develops and sells human amnion-based allograft products for active soft tissue repair and orthopedic indications.
The move combines complementary product portfolios across spine and interventional pain management, geographic footprints and customer bases.
Conformis entered into a definitive merger agreement under which restor3d will acquire all outstanding shares of common stock of Conformis.
The definitive agreement will sell the assets to Xtant Medical through a structured sale process under Chapter 11 of the U.S. bankruptcy code.
NanoBone bone graft substitute technology complements Biocomposites’ absorbable bone regeneration products.
RedPoint Medical3D offers pre-operative planning and patient-specific guides designed to deliver surgical correction of deformities customized to the patient’s foot anatomy,
SEAL specializes in foot and ankle external fixation. SEAL’s systems have produced excellent results in the treatment of foot and ankle deformities, fractures and fusions.
Medtech Concepts has developed the Playbook Ecosystem, an early stage enabling technology platformfor use in the perioperative environment.
OSSIS specializes in personalized 3D printed implants, as well as complex hip replacements, including applications in revision, tumors and trauma.
The REMI Robotic Navigation System will help advance ATEC’s procedural strategy by integrating navigation and robotics into spine workflow.
Amplitude Surgical signed a definitive agreement with Enovis for the sale of its whole Novastep business. Novastep is supported by…
Xtant acquired the Coflex and Cofix product lines from Surgalign for a total consideration of $17 million.
The company’s pending acquisition of NuVasive is about increasing operational capacity and vertical integration.
The combines will combine in an all-stock merger to create the 7th largest orthopedic company overall and 2nd largest spine player.
The move strengthens Tyber Medical’s international presence and adds a range of product options in the MIS bunion, PEEK hammertoe and screw fixation arenas.
Login
Register for a free account
As a guest member you get access to more articles and webinars every month.